Cost of Keytruda in 2025: Strategies for savings and additional information
Keytruda, also known as pembrolizumab, is a popular immunotherapy drug used to treat several types of cancer in adults. Its cost can vary significantly from person to person, influenced by a range of factors.
The cost of Keytruda is primarily determined by the type of immunotherapy and dosage prescribed. Typically, Keytruda is given as a 100 mg/4 ml intravenous injection every three weeks. The frequency of administration and the total number of doses needed also play a role in the overall cost.
Another crucial factor is the patient’s insurance coverage and plan. Insurance can drastically impact out-of-pocket expenses, with some plans covering a significant portion of the cost. The pharmacy type and location where Keytruda is purchased can also affect the final price.
The severity and stage of the cancer, as well as any other medical conditions, can influence dosage and treatment length, further impacting the cost. The broader market and regulatory environment, including competition among cancer therapies and government drug pricing policies, also play a role.
It's important to note that potential additional costs like drug wastage or administration fees can also add to the total cost. For example, about $35 per infusion cycle might be charged for administration fees.
The manufacturer's listed price per dose is reported to be over $10,000 in the U.S., with specific vial cost examples around $5,700 for 4 ml (100 mg). Adding Keytruda to chemotherapy regimens can significantly increase treatment costs, sometimes many times more than chemotherapy alone.
Fortunately, there are cost-saving programs available to help patients. Patient Assistance Programs (PAPs) sponsored by MSD Pharmaceuticals, the maker of Keytruda, can help eligible patients access the drug at low or no cost. Eligibility is often based on having a valid prescription and residency criteria.
Some pharmacies or specialty centers may offer discounts or special offers, such as buy one get one free offers in certain local contexts. Financial counseling through the cancer specialist’s office or social worker can also help maximise insurance benefits and explore copay assistance or charity options.
It's essential to remember that while the base cost of Keytruda is high due to its complex manufacturing and innovative therapy status, patients should inquire about direct assistance programs through the manufacturer and check with their healthcare providers and insurance plans for potential savings.
It's also important to note that while this information provides a general overview, it should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. For accurate and personalised information about the cost of Keytruda per dose, per month, or per year, it's best to speak with your doctor or insurance provider.
Lastly, it's worth mentioning that brand-name drugs like Keytruda typically cost more without insurance. If you have insurance, Medicare may or may not cover the cost of Keytruda, depending on your specific policy. If your insurance requires prior authorisation for Keytruda, you may pay the full cost if you start treatment without prior approval.
- The frequency of Keytruda administration and the total number of doses needed can significantly impact the cost for health insurance deciders.
- Cancer patients may find relief through cost-saving programs, such as Patient Assistance Programs (PAPs) sponsored by MSD Pharmaceuticals, which can help eligible patients access the drug at low or no cost.
- The severity and stage of a cancer, as well as any other medical conditions, can influence the cost of treatment and dosage, impacting health-and-wellness overall.
- Some pharmacies or specialty centers may offer discounts or special offers, such as buy one get one free offers, which can help patients manage their expenses associated with medical-conditions like cancer.
- Health insurance coverage and plan, along with the pharmacy type and location where Keytruda is purchased, can drastically impact out-of-pocket expenses for patients battling cancer.
